Kura Oncology, Inc. (NASDAQ:KURA) Receives $28.36 Average Price Target from Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average […]
More Stories
Head to Head Comparison: SVB Financial Group (OTCMKTS:SIVPQ) and Consumers Bancorp (OTCMKTS:CBKM)
Consumers Bancorp (OTCMKTS:CBKM – Get Free Report) and SVB Financial Group (OTCMKTS:SIVPQ – Get Free Report) are both financial services...
KBR (NYSE:KBR) Cut to “Buy” at StockNews.com
StockNews.com lowered shares of KBR (NYSE:KBR – Free Report) from a strong-buy rating to a buy rating in a report...
StockNews.com Initiates Coverage on Avalon (NYSE:AWX)
StockNews.com initiated coverage on shares of Avalon (NYSE:AWX – Get Free Report) in a research note issued to investors on...
Intuit (NASDAQ:INTU) Cut to Hold at StockNews.com
StockNews.com cut shares of Intuit (NASDAQ:INTU – Free Report) from a buy rating to a hold rating in a report...
Prestige Consumer Healthcare (NYSE:PBH) versus MediciNova (NASDAQ:MNOV) Critical Comparison
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) and MediciNova (NASDAQ:MNOV – Get Free Report) are both medical companies, but...
Darden Restaurants (NYSE:DRI) Price Target Raised to $165.00
Darden Restaurants (NYSE:DRI – Free Report) had its price target lifted by Wells Fargo & Company from $160.00 to $165.00...